Evidence map›Paper›PMID 28444521›Full record

ReviewCurrent infectious disease reports2017

Leprosy in Children.

Josafá Gonçalves Barreto, Marco Andrey Cipriani Frade, Fred Bernardes Filho, Moises Batista da Silva, John Stewart Spencer, Claudio Guedes Salgado

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Current infectious disease reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 56 citations in OpenAlex.

  1. Pediatric Borderline Leprosy with Prominent Radial Cutaneous Nerve Enlargement.The American journal of tropical medicine and hygiene · 2026
    Article
  2. Article
  3. Article
  4. The Many Hosts of Mycobacteria 9 (MHM9): A conference report.Tuberculosis (Edinburgh, Scotland) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Synthetic Phenolic Glycolipids for Application in Diagnostic Tests for Leprosy.Chembiochem : a European journal of chemical biology · 2021
    Article
  13. Article
  14. Observational
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Josafá Gonçalves BarretoSpatial Epidemiology Laboratory, Federal University of Pará, Campus Castanhal, Avenida dos Universitários, s/n, Bairro Jaderlândia Castanhal, Pará, CEP: 68746-360, Brazil. jbarreto@ufpa.br.
Marco Andrey Cipriani FradeDivison of Dermatology of Internal Medicine, Department of Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Monte Alegre, Ribeirão Preto, São Paulo, CEP: 14.049.900, Brazil.
Fred Bernardes FilhoDivison of Dermatology of Internal Medicine, Department of Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Monte Alegre, Ribeirão Preto, São Paulo, CEP: 14.049.900, Brazil.
Moises Batista da SilvaDermato-Immunology Laboratory, Federal University of Pará, Av. João Paulo II, 113 - Bairro Dom Aristides, Marituba, Pará, CEP: 67200-000, Brazil.
John Stewart SpencerDepartment of Microbiology, Immunology and Pathology, Colorado State University, 1682 Campus Delivery, Fort Collins, CO, 80523-1682, USA.
Claudio Guedes SalgadoDermato-Immunology Laboratory, Federal University of Pará, Av. João Paulo II, 113 - Bairro Dom Aristides, Marituba, Pará, CEP: 67200-000, Brazil.
Universidade Federal do Pará · BRUniversidade de São Paulo · BRColorado State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis manuscript aims to review the cutting-edge developments regarding to the diagnosis, management, and prevention of leprosy in children. RECENT

findingsLeprosy transmission still occurs continuously in some endemic areas in the world. Leprosy in children below 15 years old is a robust indicator of active source of infection in the community where they live. A special focus on children to reduce disabilities and reduce transmission is one of the core areas of interventions of the global leprosy strategy 2016-2020. Ongoing research is trying to develop better diagnostic tests and to advance chemoprophylaxis and immunoprophylaxis approaches. Early diagnosis in children can be hard because of the wide range of clinical aspects of the skin lesions and mainly due to the difficulty of performing the clinical peripheral nerve evaluation. We must maintain leprosy expertise and improve the health professionals training for leprosy diagnosis, since we still have a long journey to reach leprosy elimination.

Indexed as

ChildrenEarly diagnosisLeprosy

Identifiers

PMID28444521
OpenAlexW2609912883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.